4.6 Article

A trimeric immunoglobin G-binding domain outperforms recombinant protein G and protein L as a ligand for fragment antigen-binding purification

Related references

Note: Only part of the references are listed.
Article Radiology, Nuclear Medicine & Medical Imaging

Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors

Victor M. Baart et al.

Summary: In this study, fluorescence-guided surgery using uPAR-targeting antibody fragments resulted in earlier tumor visualization compared to the parent IgG, but at the expense of peak fluorescence intensity.

MOLECULAR IMAGING AND BIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

64Cu-labeled daratumumab F(ab′)2 fragment enables early visualization of CD38-positive lymphoma

Lei Kang et al.

Summary: The study successfully developed Cu-64-labeled Dara-F(ab ')(2) with high tumor uptake for visualization of CD38 in lymphoma models. [Cu-64]Cu-NOTA-Dara-F(ab ')(2) demonstrated rapid and high tumor uptake, promising as a potential PET imaging agent for future clinical applications. The specific binding ability and favorable imaging contrast of [Cu-64]Cu-NOTA-Dara-F(ab ')(2) were confirmed through in vitro assays and small animal PET imaging.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Medicine, Research & Experimental

Antibodies to watch in 2022

Helene Kaplon et al.

Summary: This article provides a summary of key events in the development of commercial antibody therapeutics in 2021 and a glimpse into potential events in 2022. The regulatory review process for antibody therapeutics targeting the SARS-CoV-2 coronavirus has been expedited, leading to emergency use authorizations and full approvals in multiple countries. Additionally, the late-stage commercial clinical pipeline for antibody therapeutics, excluding those for COVID-19, has seen significant growth over the past year.
Article Toxicology

Early Experience with Crotalidae Immune F(ab')2 Antivenom to Treat Arizona Rattlesnake Envenomations

Anne-Michelle Ruha et al.

Summary: This observational study in Arizona found that treatment with Fab2AV for rattlesnake envenomation resulted in no significant late hemotoxicity and no need for late retreatment with antivenom. While some patients experienced acute and delayed reactions, they were mild and easily treated.

JOURNAL OF MEDICAL TOXICOLOGY (2022)

Article Medicine, Research & Experimental

124I-Labeled Monoclonal Antibody and Fragment for the Noninvasive Evaluation of Tumor PD-L1 Expression In Vivo

Yuan Cheng et al.

Summary: Lung cancer, divided into small and nonsmall cell lung cancer, is a highly heterogeneous cancer. In this study, the F(ab ')(2) fragments of Durva were used to evaluate PD-L1 expression, and I-124-Durva-F(ab ')(2) was identified as a promising PD-L1 immunoPET tracer.

MOLECULAR PHARMACEUTICS (2022)

Article Chemistry, Analytical

Computational Engineering of Protein L to Achieve an Optimal Affinity Chromatography Resin for Purification of Antibody Fragments

Saman Rahmati et al.

Summary: This study used molecular docking and molecular dynamics simulation techniques to design engineered Protein L with higher affinity to the kappa light chain. The performance parameters of the engineered resins were evaluated, providing important insights for improving Protein L ligands for affinity chromatography.

ANALYTICAL CHEMISTRY (2021)

Article Chemistry, Multidisciplinary

A versatile platform for the tumor-targeted delivery of immune checkpoint-blocking immunoglobin G

Jie Fan et al.

Summary: Immune checkpoint-blocking antibodies can be more effectively delivered to tumors by modifying them with tumor-homing ligands fused to an IgG-binding domain (IgBD). This approach demonstrated enhanced tumor uptake and antitumor effects in mice, showing potential as a versatile platform for tumor-targeted delivery of immune checkpoint-blocking IgG antibodies.

JOURNAL OF CONTROLLED RELEASE (2021)

Article Biochemical Research Methods

Three-dimensional chromatography for purification and characterization of antibody fragments and related impurities from Escherichia coli crude extracts

Clemens Schimek et al.

Summary: This research aimed to design a purification strategy for isolating and characterizing Fab antibody fragments and related impurities. By establishing a three-dimensional chromatography method and performing mass spectrometry analysis, four different Fab molecules were successfully characterized, facilitating strain selection and optimization of cultivation conditions.

JOURNAL OF CHROMATOGRAPHY A (2021)

Article Pharmacology & Pharmacy

Design and biological evaluation of novel long-acting adalimumab Fab conjugated with the albumin binding domain

Qingbin Zhang et al.

Summary: The fusion of albumin binding domain (ABD) with antibody-binding fragments (Fab) has shown promising results in improving the pharmacokinetics and therapeutic efficacy of drugs targeting TNF alpha. The novel Fab-ABD fusions retained high TNF alpha-binding activities and exhibited significantly longer half-lives in mice, demonstrating their potential as long-acting candidates for treating inflammatory diseases.

EUROPEAN JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Antibody-Based Therapeutics for Atherosclerosis and Cardiovascular Diseases

Eunhye Ji et al.

Summary: Cardiovascular disease is a leading cause of death globally, with atherosclerosis identified as a main contributing factor. Research on antibodies targeting LDL levels and inflammatory cytokines has shown promise in treating cardiovascular diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Biochemical Research Methods

Modeling and Molecular Dynamic Simulation of F(ab′)2 Fragment of Nimotuzumab for Lung Cancer Diagnostics

Yurika Sastyarina et al.

Summary: Nimotuzumab, a humanized monoclonal antibody, selectively binds to cells with moderate to high levels of EGFR, demonstrating low toxicity and potential as a therapeutic and diagnostic agent for lung cancer. Reducing the size of immunoglobulins, such as through the development of F(ab')(2) fragments, could enhance tumor penetration and imaging quality.

BIOINFORMATICS AND BIOLOGY INSIGHTS (2021)

Review Biotechnology & Applied Microbiology

Engineering Staphylococcal Protein A for high-throughput affinity purification of monoclonal antibodies

Vinod Amritkar et al.

BIOTECHNOLOGY ADVANCES (2020)

Article Biotechnology & Applied Microbiology

Development of phage biopanning strategies to identify affinity peptide ligands for kappa light chain Fab fragments

Andre Nascinnento et al.

BIOTECHNOLOGY PROGRESS (2019)

Article Infectious Diseases

Refinement strategy for antivenom preparation of high yield and quality

Tihana Kurtovic et al.

PLOS NEGLECTED TROPICAL DISEASES (2019)

Article Biochemical Research Methods

Temperature dependence of antibody adsorption in protein A affinity chromatography

Walpurga Krepper et al.

JOURNAL OF CHROMATOGRAPHY A (2018)

Article Biochemistry & Molecular Biology

Production and Characterization of F(Ab')2 Fragments Obtained by Enzymatic Digestion from Murine Anti-MRSA PBP2a Monoclonal Antibodies

Anna Erika Vieira de Araujo et al.

APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2018)

Article Biochemical Research Methods

Routes to improve binding capacities of affinity resins demonstrated for Protein A chromatography

Egbert Mueller et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2016)

Article Biotechnology & Applied Microbiology

CF750-A33scFv-Fc-Based Optical Imaging of Subcutaneous and Orthotopic Xenografts of GPA33-Positive Colorectal Cancer in Mice

Danfeng Wei et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Functional Imaging of Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer Using Cu-64-DOTA-Trastuzumab PET

Joanne E. Mortimer et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Article Radiology, Nuclear Medicine & Medical Imaging

64Cu-DOTA-Trastuzumab PET Imaging in Patients with HER2-Positive Breast Cancer

Kenji Tamura et al.

JOURNAL OF NUCLEAR MEDICINE (2013)

Article Biochemistry & Molecular Biology

Plasma Half-life Extension of Small Recombinant Antibodies by Fusion to Immunoglobulin-binding Domains

Meike Hutt et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biotechnology & Applied Microbiology

Production and characterization of LEA29Y, a variant of cytotoxic T-lymphocyte antigen 4-immunoglobulin, in Pichia pastoris

Lin Wan et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2011)

Article Immunology

Molecular and Functional Characterization of Cynomolgus Monkey IgG Subclasses

Frederick W. Jacobsen et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Pharmacology & Pharmacy

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

E. C. Dijkers et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)

Article Medicine, Research & Experimental

Antibody fragments Hope and hype

Aaron L. Nelson

Article Multidisciplinary Sciences

Convergent solutions to binding at a protein-protein interface

WL DeLano et al.

SCIENCE (2000)